Literature DB >> 29713796

Is calcifediol better than cholecalciferol for vitamin D supplementation?

J M Quesada-Gomez1,2, R Bouillon3.   

Abstract

Modest and even severe vitamin D deficiency is widely prevalent around the world. There is consensus that a good vitamin D status is necessary for bone and general health. Similarly, a better vitamin D status is essential for optimal efficacy of antiresorptive treatments. Supplementation of food with vitamin D or using vitamin D supplements is the most widely used strategy to improve the vitamin status. Cholecalciferol (vitamin D3) and ergocalciferol (vitamin D2) are the most widely used compounds and the relative use of both products depends on historical or practical reasons. Oral intake of calcifediol (25OHD3) rather than vitamin D itself should also be considered for oral supplementation. We reviewed all publications dealing with a comparison of oral cholecalciferol with oral calcifediol as to define the relative efficacy of both compounds for improving the vitamin D status. First, oral calcifediol results in a more rapid increase in serum 25OHD compared to oral cholecalciferol. Second, oral calcifediol is more potent than cholecalciferol, so that lower dosages are needed. Based on the results of nine RCTs comparing physiologic doses of oral cholecalciferol with oral calcifediol, calcifediol was 3.2-fold more potent than oral cholecalciferol. Indeed, when using dosages ≤ 25 μg/day, serum 25OHD increased by 1.5 ± 0.9 nmol/l for each 1 μg cholecalciferol, whereas this was 4.8 ± 1.2 nmol/l for oral calcifediol. Third, oral calcifediol has a higher rate of intestinal absorption and this may have important advantages in case of decreased intestinal absorption capacity due to a variety of diseases. A potential additional advantage of oral calcifediol is a linear dose-response curve, irrespective of baseline serum 25OHD, whereas the rise in serum 25OHD is lower after oral cholecalciferol, when baseline serum 25OHD is higher. Finally, intermittent intake of calcifediol results in fairly stable serum 25OHD compared with greater fluctuations after intermittent oral cholecalciferol.

Entities:  

Keywords:  Absorption of vitamin D (metabolites); Calcifediol or 25-hydroxyvitamin D3 or 25OHD oral supplementation; Cholecalciferol or vitamin D3 oral supplementation; Conversion efficacy of vitamin D into 25OHD; Ergocalciferol or vitamin D2 oral supplementation; Metabolism of vitamin D; Vitamin D deficiency; Vitamin D supplementation

Mesh:

Substances:

Year:  2018        PMID: 29713796     DOI: 10.1007/s00198-018-4520-y

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  101 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

Review 2.  Vitamin D measurement standardization: The way out of the chaos.

Authors:  N Binkley; B Dawson-Hughes; R Durazo-Arvizu; M Thamm; L Tian; J M Merkel; J C Jones; G D Carter; C T Sempos
Journal:  J Steroid Biochem Mol Biol       Date:  2016-12-12       Impact factor: 4.292

3.  The vitamin D status of the US population from 1988 to 2010 using standardized serum concentrations of 25-hydroxyvitamin D shows recent modest increases.

Authors:  Rosemary L Schleicher; Maya R Sternberg; David A Lacher; Christopher T Sempos; Anne C Looker; Ramon A Durazo-Arvizu; Elizabeth A Yetley; Madhulika Chaudhary-Webb; Khin L Maw; Christine M Pfeiffer; Clifford L Johnson
Journal:  Am J Clin Nutr       Date:  2016-07-06       Impact factor: 7.045

4.  Vitamin D-3 intestinal absorption in vivo: influence of fatty acids, bile salts, and perfusate pH on absorption.

Authors:  D Hollander; K S Muralidhara; A Zimmerman
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

5.  Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption.

Authors:  G R Thompson; B Lewis; C C Booth
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

6.  Enterohepatic circulation of vitamin D: a reappraisal of the hypothesis.

Authors:  M R Clements; T M Chalmers; D R Fraser
Journal:  Lancet       Date:  1984-06-23       Impact factor: 79.321

7.  C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation.

Authors:  Maya Kamao; Syuichiro Tatematsu; Susumi Hatakeyama; Toshiyuki Sakaki; Natsumi Sawada; Kuniyo Inouye; Keiichi Ozono; Noboru Kubodera; G Satyanarayana Reddy; Toshio Okano
Journal:  J Biol Chem       Date:  2004-02-02       Impact factor: 5.157

8.  Comparison of oral 25-hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D.

Authors:  T C Stamp; J G Haddad; C A Twigg
Journal:  Lancet       Date:  1977-06-25       Impact factor: 79.321

9.  Exploring the genetic architecture of circulating 25-hydroxyvitamin D.

Authors:  Linda T Hiraki; Jacqueline M Major; Constance Chen; Marilyn C Cornelis; David J Hunter; Eric B Rimm; Kelly C Simon; Stephanie J Weinstein; Mark P Purdue; Kai Yu; Demetrius Albanes; Peter Kraft
Journal:  Genet Epidemiol       Date:  2012-11-07       Impact factor: 2.135

10.  Vitamin D: An overview of vitamin D status and intake in Europe.

Authors:  A Spiro; J L Buttriss
Journal:  Nutr Bull       Date:  2014-12
View more
  43 in total

1.  Baseline levels determine magnitude of increment in 25 hydroxy vitamin D following vitamin D3 prescription in healthy subjects.

Authors:  Mahmoud Ali Kaykhaei; Mahdieh Khodadoost; Ali Reza Dashipour; Zahra Haidari; Azra Karimkoshteh; Mahnaz Sandoughi
Journal:  Endocrine       Date:  2019-03-14       Impact factor: 3.633

2.  Perspective: Vitamin D supplementation prevents rickets and acute respiratory infections when given as daily maintenance but not as intermittent bolus: implications for COVID-19.

Authors:  George Griffin; Martin Hewison; Julian Hopkin; Rose Anne Kenny; Richard Quinton; Jonathan Rhodes; Sreedhar Subramanian; David Thickett
Journal:  Clin Med (Lond)       Date:  2021-02-16       Impact factor: 2.659

Review 3.  An Update on Vitamin D Deficiency in the twenty-first century: nature and nurture.

Authors:  Ashley J Stoffers; David R Weber; Michael A Levine
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-02-01       Impact factor: 3.243

Review 4.  Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis.

Authors:  Albert J Czaja; Aldo J Montano-Loza
Journal:  Dig Dis Sci       Date:  2018-10-28       Impact factor: 3.199

Review 5.  Vitamin D Metabolism Revised: Fall of Dogmas.

Authors:  Roger Bouillon; Dan Bikle
Journal:  J Bone Miner Res       Date:  2019-10-29       Impact factor: 6.741

6.  Effects of Different Vitamin D Supplementation Schemes in Post-Menopausal Women: A Monocentric Open-Label Randomized Study.

Authors:  Addolorata Corrado; Cinzia Rotondo; Daniela Cici; Stefano Berardi; Francesco Paolo Cantatore
Journal:  Nutrients       Date:  2021-01-26       Impact factor: 5.717

7.  Calcifediol or vitamin D to optimize vitamin D status: Reply to letter of M Sosas.

Authors:  R Bouillon; J M Quesada-Gomez
Journal:  Osteoporos Int       Date:  2019-10-14       Impact factor: 4.507

Review 8.  Vitamin D: Promises on the Horizon and Challenges Ahead for Fighting Pancreatic Cancer.

Authors:  Daoyan Wei; Liang Wang; Xiangsheng Zuo; Robert S Bresalier
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

9.  Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study.

Authors:  Juan F Alcala-Diaz; Laura Limia-Perez; Ricardo Gomez-Huelgas; Maria D Martin-Escalante; Begoña Cortes-Rodriguez; Jose L Zambrana-Garcia; Marta Entrenas-Castillo; Ana I Perez-Caballero; Maria D López-Carmona; Javier Garcia-Alegria; Aquiles Lozano Rodríguez-Mancheño; Maria Del Sol Arenas-de Larriva; Luis M Pérez-Belmonte; Irwin Jungreis; Roger Bouillon; Jose Manual Quesada-Gomez; Jose Lopez-Miranda
Journal:  Nutrients       Date:  2021-05-21       Impact factor: 5.717

10.  25-OHD response to vitamin D supplementation in children: effect of dose but not GC haplotype.

Authors:  Christine A Simpson; Jane H Zhang; Dirk Vanderschueren; Lei Fu; Teresita C Pennestri; Roger Bouillon; David E C Cole; Thomas O Carpenter
Journal:  Eur J Endocrinol       Date:  2021-07-07       Impact factor: 6.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.